Lead: A group of clinicians and scientists has urged the World Health Organization to recommend respirator-grade masks for all patient-facing clinical encounters, arguing that surgical masks offer insufficient protection against flu-like and Covid-style airborne infections. The appeal, sent to WHO director-general Dr Tedros Adhanom Ghebreyesus and published 9 January 2026, says respirators such as FFP2/FFP3 or N95 should be used whenever staff are face to face with patients. The authors cite lab-based filtration data and pandemic experience to argue the change would lower infections, staff sickness and burnout. The WHO says it will carefully review the letter while it updates infection prevention guidelines.
Key takeaways
- Authors: A seven-author letter, drafted after the Unpolitics conference, urges WHO to update its Infection Prevention and Control guidance to prioritise respirators for patient-facing care.
- Endorsements: The letter is backed by almost 50 senior clinicians and researchers and more than 2,000 members of the public, including clinically vulnerable people.
- Filtration differences: The authors cite studies that place surgical masks at roughly 40% filtration of Covid-sized particles, versus about 80% up to 98% for respirators (FFP2/FFP3/N95), depending on fit and model.
- Scale of prior use: At the pandemic peak, an estimated 129 billion disposable masks were used globally each month, with surgical types most common.
- Implementation proposal: Respirators should be standard in healthcare settings for all face-to-face patient care, with limited “off-ramps” allowed based on local infection levels and air filtration/ventilation.
- Equity suggestion: The authors propose WHO procurement channels could help expand respirator access in low-resource countries while phasing down surgical mask production over time.
- Evidence debate: Critics point to a lack of randomized controlled trials linking mask type to fewer infections, while proponents argue lab filtration and real-world exposure patterns provide sufficient rationale.
Background
Since the start of the Covid-19 pandemic, mask guidance has varied by country and over time. Surgical masks became ubiquitous in hospitals, clinics and public settings because they were inexpensive, widely available and designed initially to limit droplets from wearers during procedures. Respirator standards such as FFP2/FFP3 (Europe/UK) and N95 (US) target much smaller airborne particles but have been less widely distributed in routine care globally.
Early WHO statements and some national guidelines were slow to characterise SARS-CoV-2 as spreading via airborne particles, which influenced procurement and policy choices. Over the pandemic, many authorities shifted recommendations toward respirators for higher-risk settings as evidence accumulated. Masking also became politically polarised in some countries, complicating public acceptance and compliance with new guidance.
Main event
The letter circulated by the seven clinicians and scientists emerged from discussions at the online Unpolitics conference held last year and was sent to WHO chief Dr Tedros on 9 January 2026. Organiser and signatory Prof Adam Finkel of the University of Michigan School of Public Health argues surgical masks were designed to block large droplets from the wearer, not to protect the wearer from inhaled airborne pathogens, and therefore are inadequate for routine clinical protection.
The signatories recommend respirator-level masks be used every time clinicians are face to face with patients. They acknowledge potential “off-ramps”—circumstances where respirators may not be strictly required—based on community infection prevalence, room ventilation, and supplementary air filtration systems. The group suggests WHO could use its procurement system to improve respirator access in low- and middle-income countries while gradually reducing reliance on surgical masks.
The proposal is supported by nearly 50 senior clinicians and researchers and over 2,000 members of the public, including clinically vulnerable individuals. The letter has attracted public attention and is likely to provoke debate because mask policy remains politically and socially sensitive in some contexts; noted public figures and media commentators have already weighed in on both sides.
Analysis & implications
Clinically, wider respirator use in patient-facing care could reduce transmission of airborne respiratory pathogens to both patients and health workers, potentially lowering illness-related absences and mitigating staff burnout. The authors argue a proportional reduction in exposure—moving from the protective effect of a surgical mask to that of a respirator—translates into meaningful decreases in infection risk for frequent, close clinical contacts.
Operationally, switching to respirators as standard would require changes across procurement, training and fit-testing. High-filtration respirators require closer facial fit to achieve stated performance; many health systems that relied on surgical masks during the pandemic may need investment in fit-testing programs and stockpiles. There are cost implications, but proponents say WHO-backed procurement could negotiate supply and distribution at scale, lowering unit prices for low-resource settings.
From a policy perspective, revising WHO guidance would be influential even though the organisation cannot mandate national rules. An updated WHO recommendation could shift national infection control standards, hospital procurement strategies and manufacturer priorities. The suggestion to phase down surgical mask production raises transitional planning and waste-management questions given the huge volumes used during the pandemic.
Comparison & data
| Mask type | Typical particle filtration cited | Fit / leak characteristic |
|---|---|---|
| Surgical mask | ~40% of Covid-sized particles (study-derived) | Loose fit; leakage common |
| FFP2 / N95 respirator | ~80% (typical) up to 98% (model-dependent) | Tight fit when properly donned; reduced leakage |
| FFP3 respirator | Higher-end filtration approaching 98% | Designed for close facial seal; higher protection |
The table summarises the relative filtration figures cited by the letter and related studies. Lab-based particle and airflow tests show respirators outperform surgical masks when fit is adequate; real-world protection also depends on user training, duration of exposure and environmental ventilation. At the pandemic peak, global consumption of disposable masks reached an estimated 129 billion units per month, underlining the scale of any procurement shift.
Reactions & quotes
Public officials, clinicians and commentators have offered mixed responses. The WHO described the letter as requiring “careful review” and noted its infection prevention guidance is under active review with broad expert consultation. Some politicians have voiced resistance to renewed mask mandates in public settings.
“There is no rational justification remaining for prioritising or using surgical masks for routine patient-facing care,”
Letter authors to WHO
This succinct claim frames the core recommendation and is accompanied in the letter by technical argumentation about filtration and fit. Supporters highlight that respirators force inhaled air through a filter, reducing inhaled pathogen load compared with loose surgical masks.
“By sealing against the face, respirators force airflow to pass through them, filtering out airborne germs,”
Prof Trisha Greenhalgh, University of Oxford
Prof Greenhalgh’s comment, cited by the authors, explains the basic mechanism that underpins their recommendation. Detractors stress the paucity of randomized controlled trials proving that changing mask type alone reduces clinical infection rates in all settings.
Unconfirmed
- No randomized controlled trial definitively demonstrates that replacing surgical masks with respirators in all patient-facing encounters reduces infection rates across every healthcare setting—authors argue RCTs have design limitations.
- The timeline and feasibility for WHO to update and for countries to implement an immediate, global respirator recommendation remain uncertain.
- The precise global production capacity and the time needed to retool manufacturing from surgical masks to respirators at scale are not detailed in the letter.
Bottom line
The authors present a clear, evidence-framed case for upgrading mask standards in clinical care: respirators provide higher filtration and closer facial fit than surgical masks and, if deployed for all face-to-face patient care, could reduce infections and staff absences. Operational hurdles—procurement, fit-testing, costs and equitable distribution—are substantial but not portrayed as insurmountable; the letter suggests WHO procurement mechanisms could help address equity gaps.
Policymakers and hospital administrators will need to weigh the laboratory filtration evidence and pandemic experience against implementation constraints and the contested value of trial data. Watch for the WHO’s formal review outcome and any subsequent national guidance changes, which could reshape purchasing, training and infection-control norms in healthcare systems worldwide.